Aridis Pharmaceuticals Inc. logo

Aridis Pharmaceuticals Inc. (ARDS)

Market Closed
11 Aug, 20:00
NASDAQ (CM) NASDAQ (CM)
$
0. 00
0
0%
$
4.46K Market Cap
- P/E Ratio
- Div Yield
7,747 Volume
0.07 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0.05
Want to track ARDS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Aridis Pharmaceuticals Inc. logo
ARDS Aridis Pharmaceuticals Inc.
25 Feb 2026
-
-
Aridis Pharmaceuticals Inc. logo
ARDS Aridis Pharmaceuticals Inc.
3 Nov 2025
-
-
Aridis Pharmaceuticals Inc. logo
ARDS Aridis Pharmaceuticals Inc.
20 Aug 2025
-
-
Aridis Pharmaceuticals Inc. logo
ARDS Aridis Pharmaceuticals Inc.
10 Jan 2025
-
-
Aridis Pharmaceuticals Inc. logo
ARDS Aridis Pharmaceuticals Inc.
1 Nov 2024
-
-
Aridis Pharmaceuticals Inc. logo
ARDS Aridis Pharmaceuticals Inc.
11 Sep 2024
-
-
Aridis Pharmaceuticals Inc. logo
ARDS Aridis Pharmaceuticals Inc.
20 May 2024
-
-
Aridis Pharmaceuticals Inc. logo
ARDS Aridis Pharmaceuticals Inc.
28 Feb 2024
-
-
Aridis Pharmaceuticals Inc. logo
ARDS Aridis Pharmaceuticals Inc.
3 Nov 2023
-
-

ARDS Earnings Reports FAQ

What is the earnings per share (EPS) for ARDS?

The current EPS is 0.07.

What is the company's earnings growth rate?

Aridis Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Aridis Pharmaceuticals Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Aridis Pharmaceuticals Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ARDS at this time, as Aridis Pharmaceuticals Inc has no recent EPS data to calculate it.